Meaning
Contractual provisions in credit agreements permit equity sponsors or company founders to rectify a financial covenant breach through cash capital injections. An equity cure clause functions as a balance sheet repair mechanism, treating incoming junior equity contributions as additions to earnings or debt deductions to recalculate previously failed financial ratios. The term applies strictly to defined quantitative covenants within debt contracts, ceasing to operate once cure limits are exhausted or when the breach stems from negative covenants, fraud or non-curable events of default.
Mechanism Mechanics
The execution of a cure right requires the parent entity, sponsor or founder group to deposit cleared funds into the borrowing entity within a strictly defined window following quarterly financial reporting. The agreement defines whether the injected funds directly boost earnings before interest, taxes, depreciation and amortization for the calculation period, or apply solely to senior debt reduction. Lenders impose caps restricting cures to consecutive testing periods, such as limiting execution to two consecutive quarters and no more than four times over the facility lifespan.
Once deposited, the financial covenant calculations run again using the adjusted cash figures, and upon passing, the event of default is legally extinguished. This mechanism prevents immediate loan acceleration while giving the enterprise time to restructure its underlying operations.
Economic Cost
Capital injections made to cure ratio breaches demand immediate liquidity from equity holders, who must supply cash without assurance of enterprise recovery. The equity cure clause requires existing investors to evaluate whether defending a distressed capital structure is superior to surrendering enterprise control to secured creditors. For the lender, accepting cure funds reduces immediate principal risk through junior cash buffers, though it may prolong exposure to a structurally deteriorating operating model.
The capital provided for a cure remains locked in the operating entity, subordinated to senior debt and unavailable for immediate return until the underlying credit facility matures or undergoes full refinancing.
Contractual Boundary
Credit agreements carefully separate cure proceeds from standard operating performance to prevent artificial valuation inflation or unearned management incentives. Injected funds applied to cure earnings ratios are disqualified from calculating executive bonuses, general distribution baskets or future debt incurrence permissions. When the allowed number of cure events is exhausted, subsequent covenant breaches trigger unrestricted creditor remedies, including facility termination, collateral seizure and enforcement proceedings.
The cure structure acts as a temporary financial bridge, requiring underlying operational performance to rebound before external capital limits are reached. An equity cure clause trades junior equity liquidity for time to restore balance sheet compliance.
